Tricky… [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2020-01-30 19:18 2a02:8388:6bc2:ce80:59da:2536:a4ac:85cd – Posting: # 21112
Views: 8,079

Salam Osama,

» » […] with fixed (!) limits of 75.00–133.33% if CVwR <30%.
»
» I think there is a mistake here, you are right according to the fixed limit of 75-133% in the GCC Guidelines in the case of HVD (HVDP) which is absolutely not correct and cause a lot of problems in the evaluation of such drug formulation's types, BUT widen to this range is not in the case of ABE and not at all if CVwR <30% .

Of course, of course! Sorry, it was a stupid typing error. :angry:

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
20,453 posts in 4,295 threads, 1,414 registered users;
online 21 (0 registered, 21 guests [including 18 identified bots]).
Forum time (Europe/Vienna): 21:58 CET

My dear, science is a cruel mistress.    Paul Shenar (as Dr. Laurence)

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5